Viewing Study NCT05183802


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:24 AM
Study NCT ID: NCT05183802
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2022-08-10
First Post: 2021-11-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
Sponsor: Rhythm Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module